Ofra Levy-Hacham
Technik-/Wissenschafts-/F&E-Leiter bei SOL-GEL TECHNOLOGIES LTD.
Aktive Positionen von Ofra Levy-Hacham
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOL-GEL TECHNOLOGIES LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | - |
General Counsel | 01.01.2011 | - |
Karriereverlauf von Ofra Levy-Hacham
Ehemalige bekannte Positionen von Ofra Levy-Hacham
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Corporate Officer/Principal | 01.01.2010 | 01.01.2011 |
HealOr Ltd.
HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Corporate Officer/Principal | 28.05.2009 | 01.01.2010 |
SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | - | - |
GEFFEN RESIDENCE & RENEWAL LTD | Corporate Officer/Principal | - | - |
Ausbildung von Ofra Levy-Hacham
Technion-Israel Institute of Technology | Doctorate Degree |
Statistik
International
Israel | 6 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 4 |
Doctorate Degree | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Process Industries | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
GEFFEN RESIDENCE & RENEWAL LTD | Process Industries |
SOL-GEL TECHNOLOGIES LTD. | Health Technology |
Private Unternehmen | 3 |
---|---|
HealOr Ltd.
HealOr Ltd. Pharmaceuticals: MajorHealth Technology HealOr Ltd. develops and commercializes proprietary biochemical regulatory therapeutics impacting skin cells properties for the purpose of treating various skin pathologies. Its leading drug, HO/03/03, is currently undergoing Phase II/III clinical trials in the United States and India. The company is also establishing a first-in-class therapeutic pipeline for additional skin pathologies such as chronic and acute wounds, dry skin, acne, psoriasis, and others. HealOr was founded by Tamar Tennenbaum in 2002 and is headquartered in Rechovot, Israel. | Health Technology |
Savient Pharmaceuticals, Inc.
Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Biotechnology General (Israel) Ltd.
Biotechnology General (Israel) Ltd. Pharmaceuticals: MajorHealth Technology Biotechnology General (Israel) Ltd. manufactures and markets pharmaceutical products. Its products include Aminopeptidase B, Euflexxa, Zomacton, BioTropin, and Carboxypeptidase. The firm has operations in Europe, Japan, and the United States. The company was founded in 1980 and is headquartered in Kiryat Malachi, Israel | Health Technology |
- Börse
- Insiders
- Ofra Levy-Hacham
- Erfahrung